Browse > Article
http://dx.doi.org/10.5851/kosfa.2018.38.2.350

Lactobacillus plantarum DR7 Reduces Cholesterol via Phosphorylation of AMPK That Down-regulated the mRNA Expression of HMG-CoA Reductase  

Lew, Lee-Ching (School of Industrial Technology, Universiti Sains Malaysia)
Choi, Sy-Bing (School of Industrial Technology, Universiti Sains Malaysia)
Khoo, Boon-Yin (Institute for Research on Molecular Medicine, Universiti Sains Malaysia)
Sreenivasan, Sasidharan (Institute for Research on Molecular Medicine, Universiti Sains Malaysia)
Ong, Kee-Leong (Clinical Nutrition Intl (M) Sdn Bhd)
Liong, Min-Tze (School of Industrial Technology, Universiti Sains Malaysia)
Publication Information
Food Science of Animal Resources / v.38, no.2, 2018 , pp. 350-361 More about this Journal
Abstract
Hypercholesterolemia is one of the primary risk factors for cardiovascular diseases. The use of lactobacilli probiotics to reduce blood cholesterol levels have been extensively reported. However, more information is needed to evaluate the possible mechanisms involved and to identify possible targets for further therapeutic development. In this study, strains of lactobacilli were screened based on the ability to assimilate cholesterol, and prevention of cholesterol accumulation in hepatic (HepG2) and intestinal (HT-29) cells. Cell free supernatant (CFS) from Lactobacillus plantarum DR7 showed a higher ability to assimilate cholesterol, reduction in cholesterol accumulation in both HepG2 and HT-29 cells, accompanied by reduced mRNA expression of HMG-CoA reductase (HMGCR) in HepG2 (p<0.05), compared to other lactobacilli. The reduction of HMGCR expression was also diminished in the presence of an AMPK inhibitor (Compound C), suggesting that L. plantarum DR7 exerted its effect via the AMPK pathway, typically via the phosphorylation of AMPK instead of the AMPK mRNA expression in HepG2 (p<0.05). Altogether, our present study illustrated that lactobacilli could exert cholesterol lowering properties along the AMPK pathway, specifically via phosphorylation of AMPK that led to reduced expression of HMGCR.
Keywords
hypercholesterolemia; AMP-protein kinase; 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR); Lactobacillus; probiotics;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
연도 인용수 순위
1 Liong MT, Shah NP. 2005a. Acid and bile tolerance and the cholesterol removal ability of bifidobacteria strains. Biosci Microflora 24:1-10.   DOI
2 Liong MT, Shah NP. 2005b. Bile salt deconjugation and BSH activity of five bifidobacterial strains and their cholesterol coprecipitating properties. Food Res Int 38:135-142.   DOI
3 Lye HS, Rusul G, Liong MT. 2010. Removal of cholesterol by lactobacilli via incorporation and conversion to coprostanol. J Dairy Sci 93:1383-1392.   DOI
4 Ma L, Niknejad N, Gorn-Hondermann I, Dayekh K, Dimitroulakos J. 2012. Lovastatin induces multiple stress pathways including LKB1/AMPK activation that regulate its cytotoxic effects in squamous cell carcinoma cells. PLoS One 7:e46055.   DOI
5 Michael DR, Davies TS, Moss JWE, Calvente DL, Ramji DP, Marchesi JR, Pechlivanis A, Plummer SF, Hughes TR. 2017. The anti-cholesterolaemic effect of a consortium of probiotics: An acute study in C57BL/6J mice. Sci Rep 7:2883.   DOI
6 Michael DR, Moss JWE, Calvente DL, Garaiova I, Plummer SF, Ramji DP. 2016. Lactobacillus plantarum CUL66 can impact cholesterol homeostasis in Caco-2 enterocytes. Benef Microbes 7:443-451.   DOI
7 Morelli L, Capurso L. 2012. FAO/WHO guidelines on probiotics: 10 years later. J Clin Gastroenterol 46:S1-2.   DOI
8 Ooi LG, Ahmad R, Yuen KH, Liong MT. 2010a. Lactobacillus gasseri [corrected] CHO-220 and inulin reduced plasma total cholesterol and low-density lipoprotein cholesterol via alteration of lipid transporters. J Dairy Sci 93:5048-5058.   DOI
9 Ooi LG, Bhat R, Rosma A, Yuen KH, Liong MT. 2010b. A synbiotic containing Lactobacillus gasseri [corrected] CHO-220 and inulin improves irregularity of red blood cells. J Dairy Sci 93:4535-4544.   DOI
10 Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, De Ferranti SD, Floyd J, Fornage M, Gillespie C, Isasi CR, Jimenez MC, Jordan LC, Judd SE, Lackland D, Lichtman JH, Lisabeth L, Liu S, Longenecker CT, Mackey RH, Matsushita K, Mozaffarian D, Mussolino ME, Nasir K, Neumar RW, Palaniappan L, Pandey DK, Thiagarajan RR, Reeves MJ, Ritchey M, Rodriguez CJ, Roth GA, Rosamond WD, Sasson C, Towfighi A, Tsao CW, Turner MB, Virani SS, Voeks JH, Willey JZ, Wilkins JT, Wu JH, Alger HM, Wong SS, Muntner P, American Heart Association Statistics Committee and Stroke Statistics S. 2017. Heart disease and stroke statistics-2017 update: A report from the American Heart Association. Circulation 135:e146-e603.   DOI
11 Bernardeau M, Guguen M, Vernoux JP. 2006. Beneficial lactobacilli in food and feed: Long-term use, biodiversity and proposals for specific and realistic safety assessments. FEMS Microbiol Rev 30:487-513.   DOI
12 Bradford MM. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.   DOI
13 Carling D, Thornton C, Woods A, Sanders MJ. 2012. AMP-activated protein kinase: New regulation, new roles? Biochem J 445:11-27.   DOI
14 Chen K, Li S, Chen F, Li J, Luo X. 2016. Regulation of the Lactobacillus strains on HMGCoA reductase gene transcription in human HepG2 cells via nuclear factor-${\kappa}B$. J Microbiol Biotechnol 26:402-407.   DOI
15 Srivastava RAK, Pinkosky SL, Filippov S, Hanselman JC, Cramer CT, Newton RS. 2012. AMP-activated protein kinase: An emerging drug target to regulate imbalances in lipid and carbohydrate metabolism to treat cardio-metabolic diseases. J Lipid Res 53:2490-2514.   DOI
16 Hawley SA, Davison M, Woods A, Davies SP, Beri RK, Carling D, Hardie DG. 1996. Characterization of the AMP-activated protein kinase kinase from rat liver and identification of threonine 172 as the major site at which it phosphorylates AMPactivated protein kinase. J Biol Chem 271:27879-27887.   DOI
17 Hong YF, Kim H, Kim HS, Park WJ, Kim JY, Chung DK. 2016. Lactobacillus acidophilus K301 inhibits atherogenesis via induction of 24(S), 25-epoxycholesterol-mediated ABCA1 and ABCG1 production and cholesterol efflux in macrophages. PLoS One 11:e0154302.   DOI
18 Pigeon RM, Cuesta EP, Gililliand SE. 2002. Binding of free bile acids by cells of yogurt starter culture bacteria. J Dairy Sci 85:2705-2710.   DOI
19 Rattan R, Giri S, Singh AK, Singh I. 2005. 5-Aminoimidazole-4-carboxamide-1-${\beta}$-D-ribofuranoside inhibits cancer cell proliferation in vitro and in vivo via AMP-activated protein kinase. J Biol Chem 280:39582-39593.   DOI
20 Salminen A, Hyttinen JM, Kaarniranta K. 2011. AMP-activated protein kinase inhibits $NF-{\kappa}B$ signaling and inflammation: Impact on healthspan and lifespan. J Mol Med 89:667-676.   DOI
21 Weill P, Schmitt B, Chesneau G, Daniel N, Safraou F, Legrand P. 2002. Effects of introducing linseed in livestock diet on blood fatty acid composition of consumers of animal products. Ann Nutr Metab 46:182-191.   DOI
22 Zhou G, Myers R, Li Y, Chen Y, Shen X, Fenyk-Melody J, Wu M, Ventre J, Doebber T, Fujii N, Musi N, Hirshman MF, Goodyear LJ, Moller DE. 2001. Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 108:1167-1174.   DOI
23 Park YH, Hamidon F, Rajangan C, Soh KP, Gan CY, Lim TS, Abdullah WNW, Liong MT. 2016. Application of probiotics for the production of safe and high-quality poultry meat. Korean J Food Sci An 36:567-576.   DOI
24 Jones ML, Martoni CJ, Prakash S. 2012b. Cholesterol lowering and inhibition of sterol absorption by Lactobacillus reuteri NCIMB 30242: A randomized controlled trial. Eur J Clin Nutr 66:1234-1241.   DOI
25 Hu X, Wang T, Li W, Jin F, Wang L. 2013. Effects of NS Lactobacillus strains on lipid metabolism of rats fed a highcholesterol diet. Lipids Health Dis 12:67.   DOI
26 Huang Y, Wang J, Quan G, Wang X, Yang L, Zhong L. 2014. Lactobacillus acidophilus ATCC 4356 prevents atherosclerosis via inhibition of intestinal cholesterol absorption in apolipoprotein E-knockout mice. Appl Environ Microbiol 80:7496-7504.   DOI
27 Jones ML, Martoni CJ, Parent M, Prakash S. 2012a. Cholesterol-lowering efficacy of a microencapsulated bile salt hydrolaseactive Lactobacillus reuteri NCIMB 30242 yoghurt formulation in hypercholesterolaemic adults. Br J Nutr 107:1505-1513.   DOI
28 Kim Y, Yoon S, Lee SB, Han HW, Oh H, Lee WJ, Lee SM. 2014. Fermentation of soy milk via Lactobacillus plantarum improves dysregulated lipid metabolism in rats on a high cholesterol diet. PLoS One 9:e88231.   DOI
29 Lennernas H, Fager G. 1997. Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences. Clin Pharmacokinet 32:403-425.   DOI
30 Lew LC, Choi SB, Khoo BY, Liong MT. 2013. $Mn^{2+}$ and $Mg^{2+}$ improved sphingomyelinase production by Lactobacillus rhamnosus FTDC 8313 and binding affinity to sphingomyelin for generation of ceramides. Process Biochem 48:1815-1821.   DOI
31 Lin CS, Lee HT, Lee MH, Pan SC, Ke CY, Chiu AWH, Wei YH. 2016. Role of mitochondrial DNA copy number alteration in human renal cell carcinoma. Int J Mol Sci 17:814.   DOI
32 Liong MT, Dunshea FR, Shah NP. 2007. Effects of a synbiotic containing Lactobacillus acidophilus ATCC 4962 on plasma lipid profiles and morphology of erythrocytes in hypercholesterolaemic pigs on high- and low-fat diets. Br J Nutr 98:736-744.
33 Bellosta S, Paoletti R, Corsini A. 2004. Safety of statins: Focus on clinical pharmacokinetics and drug interactions. Circulation 109:III50-7.   DOI